Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2026)

Acadia Pharmaceuticals' Inventory Average history runs 11 years deep, the most recent figure standing at $33.1 million for Q1 2026.

• In Q1 2026, Inventory Average rose 47.55% year-over-year to $33.1 million; the TTM figure through Mar 2026 stood at $33.1 million (up 47.55% YoY), while the FY2025 annual figure was $28.3 million, down 1.99% from the prior year.
• Inventory Average was $33.1 million for Q1 2026 at Acadia Pharmaceuticals, up from $31.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $66.7 million in Q2 2024 to a low of $6.1 million in Q3 2022.
• Historically, Inventory Average has averaged $26.3 million across 5 years, with a median of $24.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Inventory Average jumped 772.64% in 2024, then slumped 63.23% in 2025.
• A 5-year view of Inventory Average shows it stood at $6.2 million in 2022, then soared by 353.42% to $28.3 million in 2023, then soared by 46.66% to $41.5 million in 2024, then decreased by 23.16% to $31.9 million in 2025, then grew by 3.88% to $33.1 million in 2026.
• The last three Inventory Average figures came in at $33.1 million (Q1 2026), $31.9 million (Q4 2025), and $27.6 million (Q3 2025), per Business Quant data.